Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BIOLASE Inc (NASDAQ:BIOL)

1.76
Delayed Data
As of Dec 09
 +0.05 / +2.92%
Today’s Change
0.65
Today|||52-Week Range
1.98
+109.25%
Year-to-Date
No recent news for BIOLASE Inc.

Today’s Trading

Previous close1.71
Today’s open1.77
Day’s range1.75 - 1.85
Volume220,884
Average volume (3 months)96,981
Market cap$118.9M
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)+22.22%
Earnings growth (this year)+60.00%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+1.62%
P/E ratioNM
Price/Sales1.02
Price/Book4.11

Competitors

 Today’s
change
Today’s
% change
MLSSMilestone Scientific...+0.05+3.03%
PDEXPro-Dex Inc+0.03+0.76%
ALGNAlign Technology Inc-0.68-0.68%
XRAYDentsply Sirona Inc+0.22+0.37%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateMarch 8, 2017
EPS forecast (this quarter)$0.02
Annual revenue (last year)$48.1M
Annual profit (last year)-$20.3M
Net profit margin-42.15%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Harold C. Flynn
Vice President-
Operations
Richard R. Whipp
Corporate headquarters
Irvine, California

Forecasts


Search for Jobs